Form4insider filings, from the source

SEC Form 4 · accession 0001654954-19-000383

CorMedix Inc. · CRMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 10, 2019
Accepted (ET)
Jan 11, 2019 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Restricted Stock UnitsF1,F2Jan 10, 2019A12,500—A233,879D
Restricted Stock UnitsF1,F2Jan 10, 2019A7,500—A241,379D
Restricted Stock UnitsF1,F2Jan 10, 2019A10,000—A251,379D
Common Stock, $0.001 par value per shareF3holding———135,757IWade Capital Corporation Money Purchase Plan
Common Stock, $0.001 par value per shareholding———10,000IReporting Person's Wife

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy Common Stock)F4$1.66Jan 10, 2019A75,000A—Jan 10, 2029Common Stock75,00075,000D
Stock Option (Right to Buy Common Stock)F5$0.57holding————Feb 16, 2028Common Stock40,00040,000D
Stock Option (Right to Buy Common Stock)F6$0.45holding————Jun 25, 2027Common Stock75,00075,000D
Warrant (Right to Purchase Common Stock)$0.90holding———Jan 8, 2015Jan 8, 2020Common Stock22,50022,500D
Warrant (Right to Purchase Common Stock)$0.90holding———Jan 8, 2015Jan 8, 2020Common Stock15,00015,000D

Explanation of responses